NCT00584220

Brief Summary

The purpose of this study is to determine the relative performance of a new toric soft contact lens against a toric contact lens currently available in market, specifically with regards to the comfort and vision after two weeks of use.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
96

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Sep 2007

Shorter than P25 for not_applicable

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2007

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2007

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2007

Completed
19 days until next milestone

First Submitted

Initial submission to the registry

December 20, 2007

Completed
13 days until next milestone

First Posted

Study publicly available on registry

January 2, 2008

Completed
2.1 years until next milestone

Results Posted

Study results publicly available

February 19, 2010

Completed
Last Updated

May 21, 2015

Status Verified

May 1, 2015

Enrollment Period

3 months

First QC Date

December 20, 2007

Results QC Date

August 21, 2009

Last Update Submit

May 5, 2015

Conditions

Keywords

Astigmatismvisioncomfortsatisfactioncontact lenses

Outcome Measures

Primary Outcomes (2)

  • Subjective Reported Vision

    A weighted combined score of one week and two week data calculated from individual vision-related questions asked on a 1-5 scale, 1 = most negative response to 5 = most positive, was used to derive vision outcomes. The analysis shows the outcome for both senofilcon A and alphafilcon A. If score \>0 then greater vision, if \<0 then lesser vision.

    1 week

  • Subject Reported Lens Comfort.

    A weighted combined score of one week and two week data calculated from individual comfort-related questions asked on a 1-5 scale, 1=most negative response to 5=most positive response, was used to derive comfort outcomes. The analysis shows the estimates for senofilcon A and alphafilcon A, respectively. Interpretation is \>0 indicates comfortable and \<0 indicates uncomfortable.

    1 week

Study Arms (2)

senofilcon A toric / alphafilcon A toric

OTHER

senofilcon A toric contact lenses worn daily during the first period, then alphafilcon A toric contact lenses worn daily during the second period

Device: senofilcon A toricDevice: alphafilcon A toric

alphafilcon A toric / senofilcon A toric

OTHER

alphafilcon A toric contact lenses worn daily during the first period, then senofilcon A toric contact lenses worn daily during the second period

Device: senofilcon A toricDevice: alphafilcon A toric

Interventions

contact lens

alphafilcon A toric / senofilcon A toricsenofilcon A toric / alphafilcon A toric

contact lens

Also known as: SofLens66 Toric
alphafilcon A toric / senofilcon A toricsenofilcon A toric / alphafilcon A toric

Eligibility Criteria

Age18 Years - 39 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • be at least 18 and less than or equal to 39 years of age and have a need for vision correction in BOTH eyes (monovision or uniocular fitting is NOT allowed).
  • be of Asian descent (Japanese, Chinese, Korean, Polynesian or other Asian ancestry) and have Asian Eye anatomy.
  • have successfully worn toric or spherical soft (hydrogel or silicone hydrogel) contact lenses for at least 4-weeks prior to enrollment in the study.
  • be able and willing to adhere to the instructions set forth in the protocol.
  • agree to wear their contact lenses in both eyes on a daily wear schedule for at least 8 hours per day every day during the study.
  • have a distance spherical component between -1.00 D and -5.50 D with cylinder in the range of 0.75 D to 2.25 D and cylinder axis within 10 ° of the vertical and within 20 ° of the horizontal in both eyes
  • have a best corrected manifest refraction visual acuity of at least 20/25 or better in each eye.
  • be in good general health, based on his/her knowledge.
  • read, be given an explanation of, indicate understanding of, and sign the STATEMENT OF INFORMED CONSENT.

You may not qualify if:

  • The subject is a rigid gas permeable (RGP) or daily disposable soft lens wearer.
  • The presence of clinically significant (grade 3 or 4) anterior segment abnormalities; inflammations such as iritis; or any infection of the eye, lids, or associated structures.
  • The presence of ocular or systemic disease or need for medication which might interfere with contact lens wear or which would cause the lenses to be removed more than twice a day. (i.e., Sjögren's syndrome, type II diabetes, etc).
  • Slit lamp findings that would contraindicate contact lens wear such as:
  • Pathological dry eye or associated findings
  • Pterygium or corneal scars within the visual axis
  • Neovascularization \>1mm in from the limbus
  • History of giant papillary conjunctivitis (GPC) worse than Grade 2
  • Anterior uveitis or iritis (past or present)
  • Seborrhoeic eczema, seborrhoeic conjunctivitis
  • A history of recurrent erosions, corneal infiltrates, corneal ulcer or fungal infections.
  • A known history of corneal hypoesthesia (reduced corneal sensitivity.)
  • Aphakia, keratoconus or a highly irregular cornea.
  • Current pregnancy or lactation (to the best of the subject's knowledge).
  • Active participation in another clinical study at any time during this study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

AstigmatismPersonal Satisfaction

Condition Hierarchy (Ancestors)

Refractive ErrorsEye DiseasesBehavior

Results Point of Contact

Title
Kurt Moody, OD, FAAO
Organization
Vistakon

Study Officials

  • Jason Chin, O.D.

    PRINCIPAL INVESTIGATOR
  • James Fujimoto, O.D.

    PRINCIPAL INVESTIGATOR
  • Weslie Hamada, O.D.

    Arthur T. Kobayashi, O.D., Inc.

    PRINCIPAL INVESTIGATOR
  • Dennis Kuwuabara, O.D.

    Eye Care Associates of Hawaii

    PRINCIPAL INVESTIGATOR
  • Mark Nakano, O.D.

    Mark E. Nakano Optometric Corp.

    PRINCIPAL INVESTIGATOR
  • Ikuko Sugimoto, O.D.

    Unaffilliated

    PRINCIPAL INVESTIGATOR
  • Kevin Rosin, O.D.

    Drs. Farkas, Kassalow, Resnick & Associates

    PRINCIPAL INVESTIGATOR
  • Jennifer Kao, O.D.

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restriction Type
OTHER
Restrictive Agreement
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
INDUSTRY

Study Record Dates

First Submitted

December 20, 2007

First Posted

January 2, 2008

Study Start

September 1, 2007

Primary Completion

December 1, 2007

Study Completion

December 1, 2007

Last Updated

May 21, 2015

Results First Posted

February 19, 2010

Record last verified: 2015-05